✦ LIBER ✦

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer

✍ Scribed by Vincent Chung; Elisabeth I. Heath; William R. Schelman; Brendan M. Johnson; Lyndon C. Kirby; Kerlin M. Lynch; Jeffrey D. Botbyl; Thomas A. Lampkin; Kyle D. Holen

Book ID: 105993788
Publisher: Springer
Year: 2011
Tongue: English
Weight: 397 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1756-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A fixed-dose phase I study of ZD9331, a

A fixed-dose phase I study of ZD9331, a novel non-polyglutamated inhibitor of thymidylate synthase, in patients with refractory cancer

✍ Bertucci, D.; Ratain, M.J.; Smith, R.; Mani, S.; Vogelzang, N.J.; Schilsky, R.L. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 281 KB

A designer inhibitor of a novel protein-

A designer inhibitor of a novel protein-kinase causes regression of human hormone refractory prostate cancer xenografts in nude mice

✍ M. Goldenberg-Furmanov; I. Stein; E. Pikarsky; R. Catane; M. Vigoda; M. Laster; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A Phase 1 Study of the Proteasome Inhibi

A Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients with Refractory Leukemia: a Children's Oncology Group Study

✍ Horton, T. M.; Pati, D.; Plon, S. E.; Thompson, P. A.; Bomgaars, L. R.; Adamson, 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 308 KB

387 First-in-human study of PF-05212384,

387 First-in-human study of PF-05212384, a small molecule intravenous dual inhibitor of PI3K and mTOR in patients with advanced cancer: preliminary report on safety and pharmacokinetics

✍ G.I. Shapiro; J. Molina; J. Bendell; I. Braña; J. Spicer; E. Kwak; S. Pandya; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Activity of IPI-504, a Novel Heat-Shock

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non-Small-Cell Lung Cancer

✍ Sequist, L. V.; Gettinger, S.; Senzer, N. N.; Martins, R. G.; Janne, P. A.; Lile 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 711 KB

Phase I Study of RGB-286638, A Novel, Mu

Phase I Study of RGB-286638, A Novel, Multitargeted Cyclin-Dependent Kinase Inhibitor in Patients with Solid Tumors

✍ van der Biessen, D. A. J.; Burger, H.; de Bruijn, P.; Lamers, C. H. J.; Naus, N. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 589 KB